MAM
Monaco Asset Management Portfolio holdings
AUM
$264M
This Quarter Return
+3.78%
1 Year Return
+6.34%
3 Year Return
+31.77%
5 Year Return
–
10 Year Return
–
AUM
$239M
AUM Growth
+$239M
(+20%)
Cap. Flow
-$62.8M
Cap. Flow
% of AUM
-26.28%
Top 10 Holdings %
Top 10 Hldgs %
55.66%
Holding
76
New
11
Increased
19
Reduced
22
Closed
7
Top Buys
| 1 |
VanEck Junior Gold Miners ETF
GDXJ
|
$11.3M |
| 2 |
Viatris
VTRS
|
$10.8M |
| 3 |
Teladoc Health
TDOC
|
$6.85M |
| 4 |
Occidental Petroleum
OXY
|
$6.83M |
| 5 |
The Mosaic Company
MOS
|
$5.09M |
Top Sells
| 1 |
Ginkgo Bioworks
DNA
|
$76.9M |
| 2 |
Newmont
NEM
|
$16M |
| 3 |
Agnico Eagle Mines
AEM
|
$7.85M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$7.72M |
| 5 |
Zoom
ZM
|
$6.73M |
Sector Composition
| 1 | Healthcare | 33.76% |
| 2 | Materials | 23.22% |
| 3 | Communication Services | 8.13% |
| 4 | Technology | 6.93% |
| 5 | Financials | 6.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
26
DELISTED
Walgreens Boots Alliance
WBA
| $3.27M | 0.47% |
365,000
+315,000
| +630% | +$2.82M |
|
|
B
27
Barrick Mining Corporation
B
$46.4B
| $3.18M | 0.46% |
160,000
+110,000
| +220% | +$2.19M |
|
28
QuidelOrtho
QDEL
$1.88B
| $3.07M | 0.44% |
67,325
+36,072
| +115% | +$1.64M |
|
|
29
Ginkgo Bioworks
DNA
$661M
| $3.02M | 0.44% |
370,125
-9,429,875
| -96% | -$76.9M |
|
30
Jazz Pharmaceuticals
JAZZ
$7.89B
| $2.79M | 0.4% |
+25,000
| New | +$2.79M |
|
31
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$1.91B
| $2.63M | 0.38% |
+20,000
| New | +$2.63M |
|
32
Nektar Therapeutics
NKTR
$565M
| $2.6M | 0.38% |
1,997,220
-169,212
| -8% | -$220K |
|
33
Sprott Physical Silver Trust
PSLV
$7.61B
| $2.4M | 0.35% |
230,000
| – | – |
|
34
AdvisorShares Pure US Cannabis ETF
MSOS
$910M
| $1.74M | 0.25% |
242,712
-10,000
| -4% | -$71.7K |
|
|
MREO
35
Mereo BioPharma
MREO
$277M
| $1.58M | 0.23% |
384,535
+36,407
| +10% | +$150K |
|
|
NBIS
36
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.4B
| $1.56M | 0.23% |
105,000
| – | – |
|
37
Oric Pharmaceuticals
ORIC
$1B
| $1.54M | 0.22% |
150,561
-151,089
| -50% | -$1.55M |
|
38
Nabors Industries
NBR
$527M
| $1.26M | 0.18% |
+19,500
| New | +$1.26M |
|
39
Estee Lauder
EL
$32.4B
| $1.25M | 0.18% |
+12,500
| New | +$1.25M |
|
|
NGD
40
New Gold Inc
NGD
$4.79B
| $1.2M | 0.17% |
415,000
-25,000
| -6% | -$72K |
|
|
MAG
41
MAG Silver
MAG
$2.57B
| $1.15M | 0.17% |
82,200
| – | – |
|
42
Roivant Sciences
ROIV
$8.37B
| $1.15M | 0.17% |
100,000
+60,000
| +150% | +$692K |
|
43
Forum Energy Technologies
FET
$314M
| $1.06M | 0.15% |
68,409
+8,805
| +15% | +$136K |
|
44
Xperi
XPER
$271M
| $958K | 0.14% |
103,660
-1,000
| -1% | -$9.24K |
|
45
Vanda Pharmaceuticals
VNDA
$282M
| $954K | 0.14% |
203,426
+10,500
| +5% | +$49.2K |
|
46
Capri Holdings
CPRI
$2.42B
| $893K | 0.13% |
21,034
-68,966
| -77% | -$2.93M |
|
47
Novavax
NVAX
$1.22B
| $789K | 0.11% |
62,500
-22,500
| -26% | -$284K |
|
48
VEON
VEON
$3.82B
| $708K | 0.1% |
23,262
-2,568
| -10% | -$78.1K |
|
49
Maravai LifeSciences
MRVI
$337M
| $623K | 0.09% |
75,000
-125,000
| -63% | -$1.04M |
|
50
Galapagos
GLPG
$2.05B
| $605K | 0.09% |
20,999
| – | – |
|